Profiel
Setareh van Driel Shamsili served as the Chief Medical Officer & Senior Vice President at Merus NV from 2012 to 2016.
He also worked as the Global Medical Leader-Oncology at Astellas Pharma Global Development, Inc. He later became the Chief Medical Officer at Ryvu Therapeutics SA from 2019 to 2022.
Dr. van Driel Shamsili holds a doctorate degree from Erasmus University Rotterdam and a graduate degree from Tehran University of Medical Sciences.
Eerdere bekende functies van Setareh van Driel Shamsili
| Bedrijven | Functie | Einde |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 01-02-2022 |
| MERUS N.V. | Chief Tech/Sci/R&D Officer | 01-01-2016 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Opleiding van Setareh van Driel Shamsili
| Erasmus University Rotterdam | Doctorate Degree |
| Tehran University of Medical Sciences | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERUS N.V. | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
